The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …

Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …

We identified rare coding variants associated with Alzheimer's disease in a three-stage case–control
study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-…

Multiple testing is a challenging issue in genetic association studies using large numbers of
single nucleotide polymorphism (SNP) markers, many of which exhibit linkage …

Mitochondrial (mt) impairment, particularly within complex I of the electron transport system,
has been implicated in the pathogenesis of Parkinson disease (PD). More than half of …

More than 800 published genetic association studies have implicated dozens of potential
risk loci in Parkinson's disease (PD). To facilitate the interpretation of these findings, we have …

Family-based tests of linkage disequilibrium typically are based on nuclear-family data
including affected individuals and their parents or their unaffected siblings. A limitation of such …

Parkinson disease (PD) is a chronic neurodegenerative disorder with a cumulative prevalence
of greater than one per thousand. To date three independent genome‐wide association …

Parkinson disease (PD) is a common neurodegenerative disorder caused by environmental
and genetic factors. We have previously shown linkage of PD to chromosome 8p. …

An increasing number of publications are replicating a previously reported disease-marker
association but with the risk allele reversed from the previous report. Do such "flip-flop" …